ATXS – astria therapeutics, inc. (US:NASDAQ)
Stock Stats
News
We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate [Yahoo! Finance]
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $22.00 price target on the stock.
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Form 10-Q Astria Therapeutics, For: Mar 31
Form ARS Astria Therapeutics, For: Dec 31
Form DEFA14A Astria Therapeutics,
Form DEF 14A Astria Therapeutics, For: Jun 05
Form 4 Astria Therapeutics, For: Apr 08 Filed by: AGARWAL SUNIL
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.